Detection of COVID-19 Infection from Routine Blood Exams with Machine Learning: A Feasibility Study.

The COVID-19 pandemia due to the SARS-CoV-2 coronavirus, in its first 4 months since its outbreak, has to date reached more than 200 countries worldwide with more than 2 million confirmed cases (probably a much higher number of infected), and almost 200,000 deaths. Amplification of viral RNA by (rea...

Full description

Bibliographic Details
Published in:Journal of Medical Systems Vol. 44; no. 8; pp. 1 - 13
Main Authors: Brinati, Davide, Campagner, Andrea, Ferrari, Davide, Locatelli, Massimo, Banfi, Giuseppe, Cabitza, Federico
Format: algorithm research tables/charts Journal Article
Published: Springer Nature Aug2020
Online Access:View this record in EBSCOhost
fields @attributes:
  recordID: 1
pdfLink:
plink: https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=144920605&site=ehost-live
header:
  @attributes:
    shortDbName: ccm
    uiTerm: 144920605
    longDbName: CINAHL Complete
    uiTag: AN
  controlInfo:
    bkinfo:
    dissinfo:
    jinfo:
      jid:
        01485598
        4N0
      jtl: Journal of Medical Systems
      issn: 01485598
      maglogo: N
    pubinfo:
      dt: Aug2020
      vid: 44
      iid: 8
      pid: 237
      pub: Springer Nature
      place: New York, New York
    artinfo:
      ui:
        144920605
        144920605
        144920605
        10.1007/s10916-020-01597-4
        144920605
      ppf: 1
      ppct: 12
      formats:
        fmt:
          – @attributes:
              type: T
          – @attributes:
              type: P
      tig:
        atl: Detection of COVID-19 Infection from Routine Blood Exams with Machine Learning: A Feasibility Study.
      aug:
        au:
          Brinati, Davide
          Campagner, Andrea
          Ferrari, Davide
          Locatelli, Massimo
          Banfi, Giuseppe
          Cabitza, Federico
        affil: DISCo, Università degli Studi di Milano-Bicocca, Viale Sarca 336, 20126, Milano, Italy
      sug:
        subj:
          COVID-19 Diagnosis
          Diagnostic Tests, Routine
          Machine Learning
          Human
          Italy
          Pilot Studies
          Reverse Transcriptase Polymerase Chain Reaction
          Female
          Male
          Adult
          Middle Age
          Aged
          Descriptive Statistics
          Decision Trees
          Random Forest
          Leukocyte Count
          Platelet Count
          C-Reactive Protein
          gamma-Glutamyltransferase
          Lactate Dehydrogenase
          Hematologic Tests
          Funding Source
          Adult: 19-44 years
          Middle Aged: 45-64 years
          Aged: 65+ years
          Female
          Male
      ab: The COVID-19 pandemia due to the SARS-CoV-2 coronavirus, in its first 4 months since its outbreak, has to date reached more than 200 countries worldwide with more than 2 million confirmed cases (probably a much higher number of infected), and almost 200,000 deaths. Amplification of viral RNA by (real time) reverse transcription polymerase chain reaction (rRT-PCR) is the current gold standard test for confirmation of infection, although it presents known shortcomings: long turnaround times (3-4 hours to generate results), potential shortage of reagents, false-negative rates as large as 15-20%, the need for certified laboratories, expensive equipment and trained personnel. Thus there is a need for alternative, faster, less expensive and more accessible tests. We developed two machine learning classification models using hematochemical values from routine blood exams (namely: white blood cells counts, and the platelets, CRP, AST, ALT, GGT, ALP, LDH plasma levels) drawn from 279 patients who, after being admitted to the San Raffaele Hospital (Milan, Italy) emergency-room with COVID-19 symptoms, were screened with the rRT-PCR test performed on respiratory tract specimens. Of these patients, 177 resulted positive, whereas 102 received a negative response. We have developed two machine learning models, to discriminate between patients who are either positive or negative to the SARS-CoV-2: their accuracy ranges between 82% and 86%, and sensitivity between 92% e 95%, so comparably well with respect to the gold standard. We also developed an interpretable Decision Tree model as a simple decision aid for clinician interpreting blood tests (even off-line) for COVID-19 suspect cases. This study demonstrated the feasibility and clinical soundness of using blood tests analysis and machine learning as an alternative to rRT-PCR for identifying COVID-19 positive patients. This is especially useful in those countries, like developing ones, suffering from shortages of rRT-PCR reagents and specialized laboratories. We made available a Web-based tool for clinical reference and evaluation (This tool is available at https://covid19-blood-ml.herokuapp.com/).
      pubtype: Academic Journal
      doctype:
        algorithm
        research
        tables/charts
        Journal Article
      ougenre: Article
    language: English
    refInfo:
    holdings:
      @attributes:
        islocal: N